San Diego, CA, United States of America

Pamela Sears

USPTO Granted Patents = 2 

 

Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2011-2013

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Pamela Sears – Innovator of Antimicrobial Agents

Introduction

Pamela Sears is an accomplished inventor based in San Diego, California. She has made significant contributions to the field of pharmaceutical science, particularly through her innovative work in antimicrobial agents. With a total of two patents to her name, Sears has dedicated her career to developing novel solutions for tackling bacterial infections.

Latest Patents

Among her latest patents, she has developed an 18-membered macrocyclic antimicrobial agent known as Tiacumicin. Specifically, her work on OPT-80, which is primarily composed of the R-Tiacumicin B, has resulted in promising pharmaceutical compositions that hold potential in treating bacterial infections. This compound showcases a significant advancement in the formulation of effective drugs aimed at combating resistant strains of bacteria, marking a notable contribution to modern medicine.

Career Highlights

Pamela Sears has made her mark in the pharmaceutical industry while working with Optimer Pharmaceuticals, Inc. Her role in this innovative company has allowed her to channel her expertise into creating breakthrough treatments that are now recognized within the research community. Her dedication and innovative spirit set her apart as an influential figure in the field of pharmaceuticals.

Collaborations

Sears has collaborated with notable colleagues such as Youe-Kong Shue and Chan-Kou Hwang. Working alongside these professionals in a research-intensive environment has allowed her to broaden the scope of her innovations and further enhance the development of new drugs that can significantly improve patient outcomes.

Conclusion

In conclusion, Pamela Sears is a pioneering inventor whose work in the development of 18-membered macrocyclic antimicrobial agents is making waves in the pharmaceutical industry. Her contributions to the field, particularly through her patents related to OPT-80, showcase her commitment to improving healthcare and the treatment of bacterial infections. With her ongoing dedication to innovation, Sears continues to play a vital role in the evolution of antimicrobial therapies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…